Friday 4 March 2016

Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections and urinary hesitancy.

Browse Complete Report: http://www.transparencymarketresearch.com/bph-therapeutics-market.html


Some of the medical therapies used for the treatment of BPH are as follows:
Alpha-Blockers
5- Alpha-reductase inhibitors (5-ARIs)
Alpha-Adrenergic Blockers
Phosphodiesterase-5 Enzyme Inhibitors
Anticholinergic Agents
Nonselective alpha-blockers

Some of the surgical interventions used of the treatment of BPH are as follows:
Holmium Laser Resection of the Prostate (HoLRP)
Open prostatectomy
Photoselective vaporization of the prostate (PVP)
Transurethral holmium laser ablation of the prostate (HoLAP)
Transurethral resection of the prostate (TURP)
Transurethral vaporization of the prostate (TUVP)
Transurethral incision of the prostate (TUIP)

Geographically, North America is the leading market due to high prevalence rate of benign prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged between 45 and 80 years suffer from some type of LUTS and approximately 14 million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to witness a significant growth due to the rise in various urological disorders and complications. However, BPH tends to be more progressive in African-American men owing to the presence of high testosterone level in their body.

Rise in geriatric population is expected to be one of the major driver that might drive the market. Additionally, increased awareness for prostate cancer and other urological disorders, are also expected to fuel the growth of the global BPH therapeutics market. However, high adoption rate of minimally invasive surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA) might impede the growth of the BPH therapeutics market.

Some of the key players in the benign prostatic hyperplasia (BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.

Download Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1872

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-

Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Respiratory disease is a medical condition that includes pathological conditions that affect tissues and organs which assist in making gas exchange possible in the organisms. Respiratory disease ranges from self-limiting and mild, such as the common cold, to life-threatening conditions such as lung cancer, pulmonary embolism and bacterial pneumonia. Various respiratory disease conditions include disorder of upper respiratory tract, bronchi, bronchioles, trachea, pleura and pleural cavity, alveoli, and the nerves and muscles of breathing.

Browse Full Report With Industry Expert Analysis: http://www.transparencymarketresearch.com/upper-respiratory-tract-disorder-diagnostics-therapeutics.html

Upper respiratory tract disorder or infection (URI or URTI) is a medical condition caused by acute infection that involves upper respiratory tract such as sinuses, nose, larynx or pharynx. Pharyngitis, tonsillitis, sinusitis, laryngitis, common cold, and otitis media are some of the most common upper respiratory tract disorders. Upper respiratory tract disorders are caused by direct invasion of the mucus membrane (inner respiratory tract lining) by bacteria or virus. Rhinorrhea, sneezing, nasal congestion, nasal discharge, sore throat, cough, fever, odynophagia and malaise are some of the most common symptoms observed in the patient diagnosed with upper respiratory tract disorder. Some other symptoms of the disease are headache, foul breath, hyposmia, sinus pain, shortness of breath, conjunctivitis, vomiting diarrhea, nausea, and body ache.

Upper respiratory tract disorder can be diagnosed by physical examination, laboratory tests and review of symptoms. In physical examination, physicians look for redness and swollen inside the wall of nasal cavity, white secretions on the tonsils, redness of the eyes, redness of the throat, and enlarged lymph nodes around neck and head. Laboratory testing is usually not performed for examining upper respiratory tract disorders as most of the upper respiratory tract infections are caused by viruses and no specific treatment for different types of viral upper respiratory tract disorder is available in current scenario. Some of the laboratory tests that are performed for diagnosing upper respiratory tract disorder include imaging tests (X-ray and CT scan), blood tests and sputum tests.

Upper respiratory tract disorders can be treated with antibiotics and decongestants. Acetaminophen, ibuprofen, diphenhydramine, dextromethorphan, codeine, guaifenesin, dexamethasone and prednisone are some of the antibiotics that are prescribed to the patients suffering from upper respiratory tract disorders. Oxymetazoline, phenylephrine and pseudoephedrine are some of the most commonly prescribed decongestants for the treatment of upper respiratory tract disorders. Antibiotics are rarely used as a treatment option for upper respiratory tract disorders as they are associated with many side effects and also can initiate secondary infections and bacterial resistance.

The market for upper respiratory tract disorder diagnostics and therapeutics is expected to grow at a significant CAGR during the forecast period from 2014 to 2020 owing to increasing incidences of respiratory disorders across the globe. Similarly, constant changing climate condition due to global warming and pollution has further accentuated the risk for developing upper respiratory tract disorders. This in turn is expected to drive the growth of upper respiratory tract disorder diagnostics and therapeutics market. Currently, North America accounts for the largest share of the global upper respiratory tract disorder diagnostics and therapeutics market. This is due to the fact that the U.S. has witnessed for large patient pool suffering from upper respiratory tract disorders.

Some of the major players operating in upper respiratory tract disorder diagnostics and therapeutics market include Alcon, Inc., Merck & Co., Inc., Collegium Pharmaceutical, Inc., GlaxoSmithKline plc and Verona Pharma Plc among other significant players across the globe.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World 

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Download Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3114

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Thursday 3 March 2016

A patient lifting sling refers to an assistive device that assists patients in nursing homes and hospitals to be transferred between a chair and a bed or a similar resting place with the help of hydraulics. Medical lifting slings are used widely for patients whose mobility is limited. Apart from transferring, the sling lifts help in reducing the chance of orthopedic injury caused while lifting patients. Patient care mostly requires lifting or providing the means to perform movements to do day to day activities including toileting, walking, and bathing. Such tasks comprise handling of patients who are in a fragile condition. As a result, lifting patients becomes more risky and complicated. In addition, patients and residents may also have psychological, medical, or other related conditions, which can complicate manual lifting processes.

Browse Full Report With TOC: http://www.transparencymarketresearch.com/medical-lifting-slings-market.html

Global Medical Lifting Slings Market to Register 7.80% CAGR from 2015 to 2023

The major factors that are fueling the growth of the global market for medical lifting slings include the now-aging baby boomer population, rental provisions for medical lifting sling devices that help in providing these products amongst lower-income groups, care provider safety, and legislations supporting safe patient handling and mobility. In addition, the rising government as well as private initiatives for the rights of the disabled and the elderly to offer improved health care services are also propelling the market for medical lifting slings.

According to a study presented by Transparency Market Research, in 2014, the global market for medical lifting slings was worth US$312 mn and is estimated to reach a value of US$632.8 mn by the end of 2023. The market is projected to exhibit a progressive 7.80% CAGR between 2015 and 2023.

Universal Lifting Slings Segment Led Global Medical Lifting Slings Market in 2014

On the other hand, the absence of technical expertise and training provisions in developing economies is expected to hamper the growth of the global medical lifting sling market in the next few years. The global market for medical lifting slings can be divided on the basis of product into:
Bariatric Sling
Universal Sling
Hammock Sling
Seating Sling
Toileting Sling
Stander Sling
Transfer Sling
Others

The others segment is sub-divided into tri-turner slings, bath, pool, and spa lifting slings, and pediatric slings. In 2014, the universal sling segment witnessed the highest growth rate and is expected to remain in the leading position in the coming years. The high growth of this segment can be attributed to its several beneficial features such as the ability to provide back and neck support, high comfort, and several applications including transferring a patient from a bed to chair, or from floor to bed, or chair to chair, and others. Bariatric slings hold the second position in the overall market owing to the growing prevalence of obesity across the globe.

The major players operating in the global market for medical lifting slings include GF Health Products, Inc., Joerns Healthcare, LLC, Argo Medical Inc., Etac AB, DJO Global, Invacare Corporation, Prism Medical, Bestcare, LLC, ArjoHuntleigh, and Drive DeVilbiss Healthcare.

Download Report Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6559

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-

Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Most of us want to remain independent and stay in control, but due to growing age our ability starts to decline. Hence, the concept of aged care is introduced, for an easy and better living with proper nursing facility for the higher age group. It is also known as elderly care or eldercare. It emphasizes on the personal and social needs of senior citizens as they need some assistance in their daily activities and medical support who desire to age gracefully. A special act has been taken by the Australian Government for senior citizens known as The Aged Care Act 1997 for people who are unable to live independently of their own. It promises to provides them better and longer living. It is an important distinction that the designing of house, services, activities and employee training of global elderly care falls under the unpaid market sector.

Browse Full Report With TOC: http://www.transparencymarketresearch.com/aged-care-market.html

The main agenda is to ensure that eldercare services are targeted towards people and areas with the utmost need, it facilitate access to aged care services by those who need them, irrespective of culture, race, language, gender and economic background. Focus is also given on people who are homeless or lives in remote areas and special care is also provided for lesbian, gay, bisexual, transgender and intersex (LGBTI) group. Programs are being adopted for the community based care for older people those are Commonwealth Home Support Program (CHSP) and Home Care Packages Program. These provides coordinated and personalized home care and also offers four classes of package to assist aged people with simple, low, high and very high care needs.

Aged care market has lot to offer for the special service providers who are capable to run long-term as well as short-term aged care home, nutraceutical manufacturers, pharmaceutical manufacturers, senior care furniture manufacturers and real estate companies. Special products are being marketed for aged people such as smart seat hair protector, water proof seat protectors, and bed pads.

It has already made an impact in developed countries like USA, Canada, and Australia. The aged care market is gaining its popularity in the developing countries like China, Singapore and India, as the major proportion of population is above 65 years. More elderly people will take up aged care services in the future rather depending on their families for care and support as younger people are moving to different cities leaving behind their extended family.

Aged care market can be divided on the basis of services and geography. Services can be classified as home care services and residential care services.

In home care services, they provide medical or nonmedical benefits which include personal care, skilled-nursing care, companion facilities, physical therapy and medical social services. It also includes in-home hospice care provider.

In residential aged care, they provides well maintained accommodation for those whose care cannot be met in their own homes and thus needs a special care cell. There are again two categories in residential aged care facilities these are respite care and permanent care. Respite care offers short-term and temporary care in a residential aged care facility and supports both the older people and their care givers to live at home for as long as possible. They provide both high and low care facility. On the other hand permanent care offers tailor made individual needs in the residential aged care facility.

Some of the key players can be divided on the basis of pharmaceutical manufacturer like Pfizer, Novartis, Merck & Co., GlaxoSmithKline, AstraZeneca and Novo Nordisk. On the basis of nutraceutical manufacturer like Alkemists Labs, Asiamerica Ingredients, Inc., Barrington Nutritionals, Nutralliance, Inc., and Proprietary Nutritionals Inc. Senior care furniture manufacturers can be classified as Phoenix Contract, Inc., Flexsteel and Kwalu.

Download Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9512

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
The thyroid gland is a small butterfly-shaped gland found at the base of the neck, producing thyroid hormones. The hormones produced by the thyroid influence vital functions in a human body, such as stimulating growth and other metabolic processes. Both underactive and overactive thyroid may be the root of disorders ranging from harmless goiter or an enlarged gland that may not require advanced treatment procedures, to life-threatening cancer.

Browse Full Report: http://www.transparencymarketresearch.com/thyroid-gland-disorder-market.html


According to surveys conducted recently, thyroid gland disorders, the most common of them being hyperthyroidism, hypothyroidism, and thyroid nodules, affect about 5% to 10% of the global population. The increasing incidence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis is often associated with the rising prevalence of hyperthyroidism and hypothyroidism. Iodine deficiency, which has been identified as a widespread problem globally, also aids the high incidence of thyroid gland disorders. These aforementioned factors, coupled with the growing geriatric population worldwide, fuel demand from the global thyroid disorder treatment market.

North America Dominates Global Thyroid Gland Disorders Treatment Market

In its latest report, Transparency Market Research pegs the value of the global thyroid gland disorders treatment market at US$1.8 bn in 2014. By 2023, the market is anticipated to reach US$2.4 bn, rising at a moderate yet steady CAGR of 3.10% between 2015 and 2023. Among the key regional markets, North America registered its dominance in the global thyroid gland disorders treatment market. A survey conducted by the National Health and Nutrition Examination Survey in July 2012 revealed that the prevalence of hypothyroidism in the U.S. alone varies from 4.6% to 9.5%. Alongside the high prevalence of thyroid gland disorders in North America, the region also observes favorable reimbursements policies for the medical and healthcare sector, due to which the market for thyroid gland disorders treatment is thriving in the region.

Asia Pacific to Exhibit Fastest Growth among Regional Markets for Thyroid Gland Disorders Treatment
High prevalence of thyroid disorders and growing awareness about suitable treatments for the same are observed in the emerging economies of Asia Pacific. With increasing access to thyroid disorders treatment, Asia Pacific is anticipated to exhibit the fastest growth as a lucrative market for such treatments. Increasing demand for thyroid gland disorders treatment is particularly witnessed from countries such as India, Japan, China, and Malaysia. These countries are substantially contributing to the growth of the thyroid gland disorders treatment market in Asia Pacific. Increasing consumption of generic formulations across the prominent economies of the region aids the rapid expansion of the market in Asia Pacific and also mitigates the issue of low sales revenue. As governments of the leading economies in Asia Pacific increase their investments in the healthcare sector, the thyroid gland disorders market is likely to gain much impetus.

The Latin America market for thyroid gland disorders treatment will also exhibit slow yet steady growth between 2015 and 2023. The improving healthcare scenario in the region, together with the rising incidence of thyroid disorders, will fuel the market for thyroid gland disorders treatment in Latin America.

Request For Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Wednesday 2 March 2016

Testing and analysis services are an integral part of various industries as they have the potential to save money and time by performing important analysis throughout the product development cycle. Testing and analysis services help various industries improve customer satisfaction by delivering quality products. Over the past few years, there has been an increase in the number of testing laboratories. The primary objective of testing and analysis service companies is to make sure that all products reach their highest quality before entering the market.

Browse Full Report: http://www.transparencymarketresearch.com/testing-analysis-services-market.html
 

New Food Testing Centers to Propel Global Testing and Analysis Services Market

With new testing and analysis centers being introduced by the leading players as well as new entrants, the global testing and analysis services market is predicted to expand at a rapid pace during the forecast period. Recently, Eurofins inaugurated its new food testing center to be a part of the Food Authenticity Network in the U.K. Eurofins Food Testing U.K. uses stable isotope techniques and DNA analysis to determine the geographical origin and authenticity of food and feed commodities including dairy products, meat, fruit, wine, honey, and vegetables.

The Food Authenticity Network deals with food mislabeling and fraud and also gives easy access to users to professional laboratories that provide food testing and analysis services. Eurofins Food Testing U.K. recently joined Campden BRI, the Institute of Food Research, Fera Science, West Yorkshire Analytical Services, Leatherhehttp://www.pressreleaseping.com/global-testing-and-analysis-services-market-reach-us291-bn-2023-owing-growing-trend-outsourcingad Food Research, LGC, and Premier Analytical Services under the proficiency tab of the U.K. Centers of Expertise in food authenticity testing.

The increasing number of testing and analysis service centers across the globe is expected to contribute to the growth of the global testing and analysis services market in the next few years. The global testing and analysis services market was valued at US$17.9 bn in 2014 and is expected to reach US$29.1 bn by 2023, progressing at a 5.60% CAGR during the period between 2015 and 2023.

North America to Register Maximum Demand for Testing and Analysis Services

The global testing and analysis services market is segmented on the basis of sample type, analysis type, industry, and geography. Food and beverages, pharma and medical devices, minerals, chemicals, environment and agriculture, metal and alloys, and oil and gas are some of the industries where testing and analysis services are effectively used. In 2014, in terms of revenue, the food and beverage segment dominated the global testing and analysis services market.

Based on geography, the global testing and analysis services market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East and Africa, and Rest of the World. In 2014, in terms of value, North America led the global testing and analysis services market, followed by Europe. Bureau Veritas, Intertek Group plc, Eurofins, TÜV Rheinland, Maxxam, TÜV SÜD, LECO Corporation, SGS S.A., ALS Global, Exova, Acuren, Koninklijke Philips N.V., and Applus are some of the leading companies in the global testing and analysis services market. The global testing and analysis services market is expected to be highly competitive in the years to come due to the introduction of new testing and analysis services by the new entrants.

By analysis type, the global testing and analysis services market is classified into elemental, organic, isotopic, particle size, mineralogical, metallurgical, petroleum, biomedical, and others. In 2014, the elemental testing and analysis services segment dominated the global testing and analysis services market. Around 44% of SMEs/businesses outsource elemental testing and analysis services to analytical testing companies.

Based on sample type, the global testing and analysis services market is classified into water, soil or sediment, clay mineral, metal alloy, biological sample, food, chemicals, corrosion, oil and gas, mineral, and service.

Download Free Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7643

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Parenteral nutrition refers to the intravenous administration of specialized nutrition solutions such as carbohydrates, single dose amino acids, parenteral lipid emulsions, vitamins and trace elements. This administration method requires when patient’s gastrointestinal track is not working or patients is not adequately nourished by oral or enteral route. This report studies the global parenteral nutrition market in a view of different types of nutrient i.e. carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements. The report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

Browse Full Report: http://www.transparencymarketresearch.com/parenteral-nutrition-market.html

A detailed qualitative analysis of the About factors responsible for driving and restraining the growth of the global parenteral nutrition market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Force analysis, event impact analysis and market attractiveness analysis. Additionally, market share analysis in a view of different geographies (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) and different parenteral nutrients (carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements) have also been covered under the scope of the report.

Based on type of nutrient, the global parenteral nutrition market has been has been extensively analyzed into carbohydrates, single dose amino acid solutions, parenteral lipid emulsion, trace elements, vitamins and minerals. The market size and forecast in terms of USD million for each type of nutrient has been provided for the period from 2013 to 2023. The report on the parenteral nutrition market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the parenteral nutrition market been categorized into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA) which are further divided based on the respective countries. The market size and forecast for each of these regions and countries have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the parenteral nutrition market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc (Actavis plc), Baxter International, Inc., B. Braun Melsungen AG, Claris Lifesciences Limited, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc. (Hospira, Inc.) and others.

Download Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

About Us:-

Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com